The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study
E. Jane Macaskill(Western General Hospital), J. Michael Dixon(University of Colorado Denver), Jeremy Thomas(Western General Hospital), Lorna Renshaw(NHS Lothian), Dana Faratian(Western General Hospital), Linda Williams(Edinburgh Cancer Research), Stephen L. White(Western General Hospital), John M.S. Bartlett(Edinburgh Cancer Research), Fiona Campbell(University of Birmingham), Vicky S. Sabine(Edinburgh Cancer Research), O. Young(Western General Hospital), Matthew Barber(Western General Hospital)
Cited by 55
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials
|Journal of Hypertension|2006|767